iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
Adeno-associated virus (AAV) vectors are widely used in gene therapy, particularly for liver-targeted treatments. However, predicting human-specific outcomes, such as transduction efficiency and hepatotoxicity, remains challenging. Reliable in vitro models are urgently needed to bridge the gap betwe...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2025-06-01
|
| Edice: | Molecular Therapy: Methods & Clinical Development |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2329050125000622 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|